Miao Xing, Zheng Yan, Huang Xiufang, Jiang Hui
Department of Cardiology/Endocrinolog, Fujian Provincial Hospital South Branch, Shengli Clinical Medical College of Fujian Medical University Fuzhou University Affiliated Provincial Hospital Fuzhou China.
Department of Cardiology, Fujian Provincical Hospital, Shengli Clinical Medical College of Fujian Medical University Fuzhou University Affiliated Provincial Hospital Fuzhou China.
Health Sci Rep. 2024 Aug 13;7(8):e2248. doi: 10.1002/hsr2.2248. eCollection 2024 Aug.
To evaluate the effectiveness of monitoring and managing process quality control indicators in the prevention of constipation among hospitalized patients with acute coronary syndrome (ACS).
A total of 512 hospitalized patients diagnosed with ACS between January and June 2022 were screened for inclusion in the study. Ultimately, 456 eligible participants were enrolled and divided into two groups based on the chronological order of admission: the control group and the observation group. Upon admission, both groups of patients received routine constipation prevention measures in the department. However, the observation group was subjected to targeted process quality control management, which included monitoring and managing five indicators related to constipation prevention: correctness of bowel movement recording; usage rate of laxatives; execution rate of physical interventions; implementation rate of constipation prevention education; completion rate of dietary structure and habit assessments. Data were analyzed using SPSS, with tests and tests for group comparisons.
In comparison to the control group, the observation group demonstrated significant advantages in terms of constipation incidence, completion rates of the five process quality control indicators, occurrence rates of adverse cardiac events during defecation, and PHQ-9 scores before discharge. These disparities demonstrated statistical significance with a value < 0.05.
Target-oriented process quality control management is shown to be effective in reducing constipation incidence and adverse cardiac events during constipation episodes, as well as alleviating depressive symptoms among ACS patients, thus providing a safe and effective approach to constipation prevention.
评估监测与管理过程质量控制指标在预防急性冠状动脉综合征(ACS)住院患者便秘中的有效性。
筛选2022年1月至6月期间共512例诊断为ACS的住院患者纳入本研究。最终,456名符合条件的参与者被纳入并根据入院时间顺序分为两组:对照组和观察组。入院时,两组患者均在科室接受常规便秘预防措施。然而,观察组接受针对性的过程质量控制管理,包括监测和管理与便秘预防相关的五个指标:排便记录的正确性;泻药使用率;物理干预执行率;便秘预防教育实施率;饮食结构和习惯评估完成率。使用SPSS进行数据分析,采用检验和检验进行组间比较。
与对照组相比,观察组在便秘发生率、五个过程质量控制指标的完成率、排便时不良心脏事件发生率以及出院前PHQ-9评分方面均显示出显著优势。这些差异具有统计学意义, 值<0.05。
针对性的过程质量控制管理被证明在降低便秘发生率和便秘发作期间的不良心脏事件,以及减轻ACS患者的抑郁症状方面是有效的,从而为便秘预防提供了一种安全有效的方法。